Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2009 Sep 15;284(47):32932–32941. doi: 10.1074/jbc.M109.024273

Structure and Interdomain Dynamics of Apoptosis-associated Speck-like Protein Containing a CARD (ASC)*

Eva de Alba 1,1
PMCID: PMC2781708  PMID: 19759015

Abstract

The human protein ASC is a key mediator in apoptosis and inflammation. Through its two death domains (pyrin and CARD) ASC interacts with cell death executioners, acts as an essential adapter for inflammasome integrity, and oligomerizes into functional supramolecular assemblies. However, these functions are not understood at the structural-dynamic level. This study reports the solution structure and interdomain dynamics of full-length ASC. The pyrin and CARD domains are structurally independent six-helix bundle motifs connected by a 23-residue linker. The CARD structure reveals two distinctive characteristics; helix 1 is not fragmented as in all other known CARDs, and its electrostatic surface shows a uniform distribution of positive and negative charges, whereas these are commonly separated into two areas in other death domains. The linker adopts residual structure resulting in a back-to-back orientation of the domains, which avoids steric interference of each domain with the binding site of the other. NMR relaxation experiments show that the linker is flexible despite the residual structure. This flexibility could help expand the relative volume occupied by each domain, thus increasing the capture radius for effectors. Based on the ASC structure, a tentative model is proposed to illustrate how ASC oligomerizes via CARD and pyrin homophilic interactions. Moreover, ASC oligomers have been analyzed by atomic force microscopy, showing a predominant species of disk-like particles of ∼12-nm diameter and ∼1-nm height. Taken together, these results provide structural insight into the behavior of ASC as an adapter molecule.

Introduction

Apoptosis and inflammation are biologically related processes that depend on multiple protein-protein binding events leading to the formation of apoptotic and inflammatory complexes. These interactions are to a large extent mediated by members of the death domain superfamily, which comprises four family subclasses (1): i.e. death domains (DD),2 death effector domains (DED), caspase recruitment domains (CARD), and pyrin domains (PYD). Most members of this superfamily are composed of multiple domains, typically from two to six, which mediate homotypic interactions within each domain subfamily (1). In particular, DD/DD, DED/DED and CARD/CARD interactions have been characterized structurally (1), whereas the PYD/PYD binding mode is currently unknown.

The human protein ASC (2, 3) is a member of the death domain superfamily bearing two death domains (N-terminal PYD, C-terminal CARD). ASC functions as an adapter molecule in both apoptosis and inflammation by interacting with Bax (4, 5) and caspases (6, 7) during apoptosis and by regulating the caspase-1-dependent inflammatory form of cell death named pyroptosis (8). ASC involvement in the cell death machinery seems to be connected to human diseases such as cancer. In fact, ASC gene transcription is impeded by aberrant DNA methylation in numerous types of human cancer (breast, ovarian, brain, and prostate) (9).

Additionally, ASC acts as an integral adapter in the assembly of the inflammasome, a multiprotein complex necessary to activate caspase-1 leading to the processing and secretion of proinflammatory cytokines (1012). The inflammasome comprises the NOD/NACHT-LRR proteins, ASC, and caspases 1 and 5 (13). NOD/NACHT-LRR proteins (14) recognize pathogen-associated molecular patterns and lead to a cascade of interactions responsible for caspase-1 activation. This molecular cascade regulates the processing of interleukin-1β family members. The several types of inflammasomes identified to date differ in the NOD/NACHT-LRR protein (Ipaf, NALP1, NALP2, cryopyrin/NALP3, and pyrin) and the cellular mechanism followed to activate caspase-1. The NALP2-, cryopyrin/NALP3-, and pyrin-dependent inflammasomes do not associate directly with caspase-1 and require ASC as an adapter (1519). This assembly is mediated by homophilic interactions between the PYD and CARD of ASC with the PYD-containing NOD/NACHT-LRR and the CARD of procaspase-1 (13, 15, 20, 21).

In addition, ASC oligomerizes into supramolecular and functional complexes. For instance, inflammatory stimuli in macrophages induce the formation of a large ASC complex named pyroptosome, which is a potent caspase-1 activator responsible for pyroptosis (8). This ASC assembly has been observed in vitro as well (22). During apoptosis, ASC also oligomerizes into structures (2, 6) that serve as the scaffold for supramolecular platforms involved in caspase activation (13, 18). The multiple functions of ASC have granted it the nickname of “molecular glue” (10).

ASC is an attractive candidate in the death domain superfamily for structural studies because it performs critical roles in apoptosis and inflammation with the simplest molecular architecture consisting of two domains. The structural and dynamic characterization of full-length ASC could help to improve our current understanding of the role played by interdomain conformational dynamics and the interplay between domains in the function of death domain proteins. What is known structurally on this subject emerges from the reported 3D structures of only two proteins with more that one death domain: i.e. FADD (composed of a DD and a DED) (23) and MC159 (a tandem of two DEDs) (24). The structure of FADD shows a tail-to-tail orientation of its two domains that results from the short (six-amino acid) linker connecting them and few contacts between both domains located in the vicinity of the linker. In contrast, the two DEDs of MC159 form a binding interface, as expected from the propensity of death domains to form homotypic interactions within members of the same subfamily (1). To date, the 3D structure of the pyrin domain of ASC is known (25). On the basis of this structure it has been suggested that the PYD/PYD interaction is analogous to the CARD/CARD binding mode (26, 27). However, the absence of the CARD in this structure precludes investigating the interplay between domains in ASC function.

This study reports the high resolution NMR structure of full-length ASC together with the analysis of its interdomain dynamics using NMR relaxation techniques. The results show that the PYD and CARD of ASC are structurally independent and connected by a flexible linker. The linker displays some local structure that restrains interdomain dynamics, leading to a back-to-back orientation of the two domains that facilitates binding to multiple partners. The interdomain flexibility of ASC could operate in a “fly-casting” fashion (28) to increase its ability to capture binding partners. By combining the ASC structure with the single known 3D structure of a CARD/CARD complex (27), a model for ASC dimerization is proposed. The model illustrates that the PYD and CARD of ASC are confined in space without obstructing the binding of each domain to their respective partners and suggests a possible way to oligomerize into larger assemblies. To complement the high resolution structural and dynamics studies by NMR, ASC oligomers have been analyzed by atomic force microscopy showing that ASC oligomerizes into ∼12-nm-diameter and ∼1-nm-height disk-like particles. The results reported herein provide structural and dynamic insights into how ASC can operate as molecular glue through protein-protein interactions mediated by its two death domains.

EXPERIMENTAL PROCEDURES

Protein Cloning, Expression, and Purification

Cloning, expression, and purification of human ASC has been reported elsewhere (29).

NMR Spectroscopy for Structural Studies

NMR samples were prepared at 0.2 mm ASC, 5 mm d15-Tris(2-carboxyethyl)phosphine, 0.1 mm NaN3, pH 3.8, 5% D2O/H2O, and 100% D2O. NMR experiments were acquired at 298 K in a Bruker Avance 600 MHz spectrometer equipped with a triple-resonance cryogenic probe. Sequence backbone assignments were obtained from the following experiments: [1H,15N]-HSQC, 3D HNCO, 3D HNCACB, and 3D CBCA(CO)NH. Side-chain assignments were obtained from 3D HBHA(CO)NH, 3D (H)CC(CO)NH-TOCSY, and 3D H(CCCO)NH-TOCSY. NOE data were obtained from 3D 15N-[1H,1H]-NOESY (90-ms mixing time) and four-dimensional [1H-13C,1H-13C]-NOESY (90-ms mixing time). Information on NMR experiments for protein structure determination can be found elsewhere (30, 31). All experiments were processed with NMRPipe (32) and analyzed with PIPP (33). Spectra resulting from some of these experiments are shown in Fig. 1 and supplemental Fig. S1.

FIGURE 1.

FIGURE 1.

ASC is properly folded at pH 3.8 and oligomerizes at concentration ∼1 mm. A, shown is a [1H,15N]-HSQC spectrum of 13C,15N-labeled ASC at pH 3.8. Residue numbers are assigned to the corresponding signals. Assignment of the central region of the spectrum is not shown for clarity. “sc” denotes side chain. B, shown is the 1H amide region in one-dimensional projections of [1H,15N]-HSQC spectra of 0.7 mm 13C,15N-labeled ASC at pH 3.8. The black, green, and red lines correspond to spectra acquired ∼1 h, ∼2 h, and 5 days after sample preparation, respectively.

Several attempts were made to obtain residual dipolar couplings, including the use of bicelle (34) and bacteriophage (35, 36) alignment systems. ASC appears to disrupt bicelle formation resulting in the absence of protein alignment. In the presence of bacteriophages, the NMR spectrum mostly shows signals corresponding to the flexible linker, therefore, precluding the measurement of sufficient data to include in the structure calculation protocol.

Structure Calculation

Peak intensities from NOESY experiments were translated into a continuous distribution of interproton distances. Distances involving methyl groups, aromatic ring protons, and non-stereospecifically assigned methylene protons were represented as a summation averaging, (Σr−6)−1/6 (37). Errors of 40 and 30% of the distances were applied to obtain lower and upper distance limits. 78 hydrogen bond distance restraints (rNH-O = 1.9–2.5 Å, rN-O = 2.8–3.4 Å) were defined according to the experimentally determined secondary structure of the protein. The TALOS program (38) was used to obtain 311 ϕ and ψ restraints for those residues with statistically significant predictions. Structures were calculated with the program X-PLOR-NIH 2.16.0 (39). The starting structure was heated to 3000 K and cooled in 30,000 steps of 0.002 ps during simulated annealing. The final ensemble of 20 NMR structures was selected based on lowest energy and no restraint-violation criteria. The 20 lowest energy conformers have no distance restraint violations and no dihedral angle violations greater than 0.35 Å and 4.5°, respectively. Structure quality was assessed with PROCHECK-NMR (40) and MolProbity (41). Structures were analyzed with MOLMOL (42). Coordinates were deposited in the Protein Data Bank with accession code 2KN6.

Backbone 15N Relaxation Measurements

Relaxation experiments were performed at 298 K in a Bruker Avance spectrometer operating at 600 MHz. The 15N T1, T, and {1H}-15N NOE data were obtained with specific NMR pulse sequences (43, 44). The recycle delay to measure 15N T1 and T was 1 s, whereas {1H}-15N NOE experiments used 3.2s. All experiments were acquired in an interleaved manner to minimize the effects caused by spectrometer drift. The relaxation delays of T1 experiments were the following: 12, 36, 100, 244, 484, 964, 1284, and 1604 ms. T experiments used a 15N continuous spin-lock field of 2.5 kHz. T, instead of T2 relaxation times were acquired because resonance offset effects are significant in T2 experiments, whereas they can be corrected in a straightforward manner for T data using the equation (45),

graphic file with name zbc04709-9540-m01.jpg

where θ = tan−1NNB1), ΩN is the resonance offset, and γNB1 is the strength of the spin-lock field. T2 values can be obtained from Equation 1, as T1, T, and θ are known.

Relaxation times were calculated by fitting peak-intensity dependence with the experiment relaxation times to an exponential function given by I(t) = I0e[(−1/T)t] (T = T1, T). T1 and T values are averages of two separate measurements. The {1H}-15N NOE values were calculated from the ratio of peak intensities obtained from experiments performed with and without 1H presaturation. The 1H frequency was shifted off-resonance in the unsaturated experiments. The pulse train used for 1H presaturation utilized 162° pulses separated by 50-ms delays and was applied for a total of 2.2s. The recycle time is reasonably long; however, NOE values were corrected for incomplete 1H magnetization recovery as previously described (44).

Apparent rotational correlation times were obtained assuming full anisotropy, as described elsewhere (46), from relaxation data of residues that do not undergo slow conformational averaging and show {1H}-15N NOE values larger than 0.65 (43). The parameters of the rotational diffusion tensor are shown in supplemental Table S1.

Atomic Force Microscopy Imaging

Mica surfaces were covered with 3 μl of protein solution at either pH 3.8 or 7.0 and incubated for 30 s. The surface was subsequently rinsed with the respective buffers at pH 3.8 and 7.0 and dried. Tapping mode imaging in air was conducted with a Multimode Atomic Force Microscope (Veeco Instruments, Santa Barbara, CA) using a Nanoscope IIIa controller and a J scanner. Veeco nanoprobe tips TESP7 with a resonance frequency of 320 kHz and a spring constant k = 42 newtons/m were used. Scan rates were set at 1Hz.

Molecular Modeling

The solution structure of ASC was used as the monomer template to build the model for the ASC dimer by superimposing the CARD of ASC to Apaf-1-CARD and caspase-9-CARD complex (27). The model was created with the program MOLMOL (42).

RESULTS

ASC Propensity to Oligomerize by NMR and AFM

ASC self-associates in vivo during apoptosis and inflammation (2) and is capable of forming functional supramolecular assemblies in vitro (22). The oligomerization of ASC poses significant challenges for NMR structural studies regarding protein solubility and particle size. It is, therefore, critical to find conditions to minimize oligomerization at the relatively high concentrations used in protein NMR (∼1 mm).

ASC solubility is very low at neutral pH. The soluble fraction of ASC at pH 7 cannot be detected with Coomassie Blue staining in polyacrylamide gel electrophoresis (detection limit 50–100 ng) and results in few observable signals with intensity slightly above the noise level in a spectrum acquired using fast NMR acquisition techniques (47) (supplemental Fig. S2). In contrast, under acidic conditions (pH ∼ 4) ASC solubility improves and can readily be detected by NMR. The dispersion of NMR signals in the [1H,15N]-HSQC spectrum of ASC (Fig. 1A and supplemental Fig. S2) indicates that the protein is properly folded at this pH. However, NMR signal intensity decreases over time with no concomitant changes in the chemical shifts (Fig. 1B). This result suggests that ASC forms oligomers of considerable size that tumble too slowly to be observed in the NMR spectrum. The NMR signal intensity of 0.7 mm ASC decays to ∼80% after ∼3 h of sample preparation and to ∼30% within the first 5 days (Fig. 1B). In contrast, at 0.2 mm protein concentration, signal intensity decays to 98% after ∼3 h of sample preparation and to ∼80% within the first 24 h. NMR signal intensity continues decaying to ∼75% of the original signal, reaching a plateau after ∼3 days of sample preparation. Therefore, by decreasing the protein concentration to 0.2 mm, the effect of ASC oligomerization in NMR signal intensity is significantly reduced, whereas it is still possible to acquire NMR triple-resonance spectra with a signal enhancing cryogenic probe.

Because the capability of ASC to oligomerize is basic to its function, oligomerization at neutral and acidic pH was investigated by scanning atomic force microscopy. AFM images show that ASC forms oligomers of similar size and shape at both pH values (Fig. 2, A and B). The predominant species appears like disks of ∼1-nm height and ∼12-nm diameter (see the section images in Fig. 2, A and B). Taken together, the NMR and AFM data indicate that ASC is able to oligomerize in vitro into particles of similar structural features under both pH conditions. Based on these results, it is reasonable to assume that the structure of ASC is not perturbed at acidic pH. Under acidic conditions, the oligomerization reaction likely favors the monomeric form, increasing in turn the solubility of ASC and, thus, leading to a larger fraction of monomers observable by NMR.

FIGURE 2.

FIGURE 2.

Tapping mode AFM images of ASC oligomers. Left, shown are amplitude images of ASC oligomers (circled) at pH 7.0 (A) and pH 3.8 (B). Right, shown are sections of height images of ASC oligomers circled in blue (A) and blue and red (B). The total section in A flanks two particles simultaneously and is, therefore, two times the length (70 nm) of the section in (B) (35 nm), which flanks each particle individually.

To investigate whether the possible oligomerization of ASC at 0.2 mm interferes with structural and dynamics studies, NMR relaxation measurements were performed. Backbone amide (15N) magnetic relaxation experiments provide rotational correlation times (τc), which directly depend on the molecular size and shape (46, 48). In the presence of aggregation, measured τc values should be larger than theoretical values derived from the molecular size (49). Differences between the two can also originate from the low sphericity of the protein and from dynamic processes associated, for example, to interdomain motion. The former case generally results in experimental τc values larger than the prediction. The experimental τc value of ASC is small for its size (∼22 kDa) (Table 1), indicating that the fraction of ASC molecules observable by NMR tumbles as monomers. The discrepancy with the theoretical value (Table 1) could, therefore, be due to interdomain dynamics in ASC (see below). In addition, amide 15N transverse relaxation times (T2) depend on the protein rotational correlation time but are reduced in the presence of aggregation (50). For ASC, the average T2 value of the two domains (72.5 ± 5.5 ms) agrees with the measured correlation time. These results indicate that ASC oligomerization does not have significant effects under the conditions used for the following NMR structural and dynamics studies.

TABLE 1.

Rotational correlation times (τc)

System No. of structured residues τca (ns) τcb (ns)
Full-length ASC 168 9.8 12.0
ASC-PYD 87 10.5 6.5
ASC-CARD 78 9.2 5.8
ASC2 84 6.2c 6.3
Calmodulin N-terminal domain 73 7.1c 4.1
Calmodulin C-terminal domain 66 6.3c 3.7

a Experimental values from magnetic relaxation.

b Theoretical values obtained with a spherical model (49) using the number of residues specified and the temperature corresponding to each case: ASC (298 K), ASC2 (298 K), and calmodulin (308 K).

c Reported experimental values: ASC2 (56), calmodulin (43).

High Resolution Structure of Full-length Human ASC

The three-dimensional structure of ASC was determined with 3046 NOE-derived distances and 311 dihedral and 78 hydrogen bond restraints. The 20 lowest energy conformers of ASC do not show distance or angle restraint violations greater than 0.35 Å and 4.5°, respectively (Table 2). The ensemble of structures does not show significant deviations from covalent geometry and is well defined by the NMR data, resulting in low atomic coordinate precision for the backbone and all heavy atoms (Table 2). Structural validation data of the ASC structure obtained with MolProbity (41) in comparison to average values calculated for all NMR PYD and CARD structures deposited in the Protein Data Bank indicate that the structure of ASC is of comparable quality (Table 3). The equivalent resolution provided by PROCHECK-NMR (40) of the ASC structure compared with x-ray structures is between 1 and 1.8 Å (supplemental Fig. S3).

TABLE 2.

Structural statistics of human ASC

Statistics were calculated for the 20 conformers with the lowest overall energies and no NOE or dihedral angle restraint violations greater than 0.35 Å and 4.5°, respectively.

Root mean square deviations
20 lowest energy conformers Lowest energy conformer
Restraints
    Distances, Å (3046) 0.0244 ± 0.0009 0.0247
        Intraresidue (1547)
        Sequential |ij| = 1 (497)
        Short range |ij| ≤ 5 (511)
        Long range |ij| ≥ 5 (491)
    Hydrogen bonds, Å (78) 0.022 ± 0.002 0.021
    Dihedrals (φ ψ, °) (311) 0.59 ± 0.04 0.59

Deviations from ideal covalent geometry
    Bonds, Å 0.00611 ± 0.00007 0.00606
    Angles 0.706 ± 0.005° 0.696°
    Impropers 0.39 ± 0.02° 0.40°

Structure quality
    Lennard-Jones potential energy (kcal mol−1)a −912 ± 9 −912
    Ramachandran (PROCHECK-NMR (40)) 88% (residues in most favored regions)1.4% (residues in disallowed regions) 88% (residues in most favored regions)1.4% (residues in disallowed regions)
    Coordinate precision, Å Residues 3–88 Residues 118–192
        Backbone heavy atoms 0.4 ± 0.1 0.46 ± 0.07
        All heavy atoms 0.87 ± 0.08 1.03 ± 0.08

a The Lennard-Jones van der Waals energy was calculated with the CHARMM PARAM19/20 parameters and was not included in structure calculation.

TABLE 3.

MolProbity (41) structure validation for the representative structure of ASC and average values for the reported PYD and CARD NMR structures

ASC Average valuea
All-atom contacts, Clashscore for all atomsb,c 72 43
MolProbity Scoreb 31 23
Ramachandran outliers 4.7% 3.0%
Ramachandran favored 90.2% 85.8%
Rotamer outliers 9.5% 14.5%
Cβ deviations > 0.25 Å 0 0.64
Residues with bad bonds 0% 1.0%
Residues with bad angles 0% 0.3%

a Average values were calculated using the representative model of the reported CARD and PYD NMR structures: isolated PYD of ASC (25), NALP1-PYD (55), ASC2 (56), NALP10-PYD (PDB entry 2DO9), PYD of myeloid cell nuclear differentiation antigen (PDB entry 2DBG), Apaf-1-CARD (26, 65), ICEBERG (66), RAIDD-CARD (67), NOD1-CARD (Ref. 68, and PDB entry 2DBD).

b 100 is the best structure quality score.

c Clashscore is the number of serious steric overlaps (>0.4 Å) per 1000 atoms.

The NMR structure of full-length ASC shows two six-helix bundle domains (PYD and CARD) connected by a 23-residue-long linker (Fig. 3A). No interdomain NMR-derived contacts (NOEs) were observed, and neither domain shows NOEs with the linker; therefore, the PYD and CARD do not interact with each other. This result agrees with the previously observed propensity of death domains to participate in homotypic interactions within each subfamily (1) and the description of ASC as an adapter protein with two homophilic protein-protein interacting domains (51). Although long, the linker of ASC (residues 90–112) adopts some residual structure as evidenced by the presence of short-range NOEs. In addition, the 13Cα chemical shifts (29) deviate from random coil values. NOE data involving residues 90–94 (supplemental Table S2) and some positive 13Cα secondary shifts in this region (Fig. 4A) suggest that it adopts residual turn-type conformations. In contrast, 13Cα chemical shift deviations are almost consistently negative from residues 95 to 112 (Fig. 4A), pointing to the formation of low populated extended structures (52). These results are supported by the empirical program TALOS (38), which using a combination of ASC chemical shifts of several nuclei (15N amide, 13Cα, 13Cβ, 13C′, 1Hα) as input data, predicts most linker residues to populate extended structures (Fig. 4B). It is noteworthy that only five residues fall outside the extended structure region of the Ramachandran plot. Three of them (Gln-91, Gly-92, and Gly-94) belong to the fragment 90–94 that, based on NOE data, is likely adopting turn or short-helix conformations. The other two residues (Gly-99 and Gly-111) are comprised in the fragment 95–112 and fall in the left-handed helix region characteristic of Gly. The propensity of the linker to adopt extended structure is not surprising on the basis of its amino acid composition. Residues such as Ser, Ala, Gly, and Pro, present in the linker of ASC, are known to bias the polypeptide chain toward such conformations (5354). In particular, two consecutive Pro residues (Pro-103 and Pro-104 in the linker of ASC) favor the polyproline II or collagen conformation (54), which is a common residual extended structure found in protein loops and linkers connecting domains in modular proteins (53).

FIGURE 3.

FIGURE 3.

Solution structure of full-length human ASC and comparison to representative PYD and CARD known structures. A, shown is a ribbon representation of the solution structure of full-length human ASC. Helices of the CARD are colored in dark green (front) and light green (back). Helices of the PYD are colored in red (front) and orange (back). B, left panel, shown is the superposition of the structures of full-length ASC PYD (red) and NALP1-PYD (blue) (55). Right panel, shown are full-length ASC PYD (red) and NALP10-PYD (orange) (PDB entry 2DO9). C, shown is the superposition of the structures of full-length ASC CARD (green) and Apaf-1-CARD (navy) (26). Helices are shown as cylinders in B and C. D, electrostatic surface of full-length ASC CARD and Apaf-1-CARD (only the negatively charged area is shown in Apaf-1-CARD). Protein orientation is equivalent.

FIGURE 4.

FIGURE 4.

A, ASC 13Cα chemical shifts deviations from random coil values (64) versus residue number are shown. The helices and interdomain linker are indicated. B, a Ramachandran representation of ϕ and ψ values predicted by TALOS (38) for residues in the linker of ASC is shown. Red circles highlight residues in the fragment 90–94 not predicted to populate extended conformations. Most residues in the fragment 95–112 are clustered in the extended structure region with the exception of Gly-99 and Gly-111. Bars indicate uncertainties in the predicted values.

In contrast to the structure of full-length ASC reported here, in the solution structure of the protein FADD, few interdomain NMR contacts have been observed between the DD and the DED (23). These interactions are not located in the consensus binding sites of each domain and are spatially close to the short linker (6 amino acids) connecting them. The linker length and flexibility could, thus, emerge as important factors in the structure and dynamics of the death domain superfamily.

The PYD of full-length ASC shares some general characteristics with other known PYD structures, including the long loop between helices 2 and 3 (Figs. 3A and 4), a feature of PYDs absent in other death domains. However, it is worth noting several differences with the isolated PYDs of NALP1 (55) and NALP10 (PDB entry 2DO9). These show a disordered loop in place of helix 3 in the PYD of ASC (Fig. 3B). Helices 1 and 6 are also shorter in the PYD of NALP1 (Fig. 3B). These structural differences result in high root mean square deviation values (9.7 Å for NALP1-PYD and 7.3 Å for NALP10-PYD) and might be related to their differences in biological function. In fact, NALPs contain additional domains and leucine-rich motifs, suggesting different roles in inflammasome formation. In contrast, the PYD-only protein ASC2 (56), which is thought to modulate ASC-mediated autoimmune response through PYD/PYD interactions (57), is significantly similar to the PYD of ASC at the structural level (root mean square deviation = 1.36 Å) and also displays the helix 3. Not surprisingly, the PYDs of both proteins share a high degree of sequence identity (64%). The PYD of full-length ASC and the isolated PYD (25) are structurally very similar as well (root mean square deviation = 1.37 Å). This result indicates that the presence of the CARD does not perturb the structure of the PYD in ASC and agrees with the absence of interdomain contacts.

Full-length ASC CARD shows structural peculiarities compared with other known CARDs. In all previously reported CARD structures, helix 1 is bent or broken into two smaller helices, named H1a and H1b. The hinge connecting these two fragments is involved in protein-protein interactions according to structural studies on the complex between Apaf-1-CARD and caspase-9-CARD (26, 27). Fragment H1a is missing in the CARD of ASC. Helix 1 spans residues Gln-117 to Val-126 and is preceded by a relatively ordered turn (His-113—Asp-116) (Fig. 3A). A comparison of the CARD structure of full-length ASC with the solution structure of Apaf-1-CARD (26), which is one example with the two H1a and H1b fragments, is shown in Fig. 3C. The H1a fragment displayed by Apaf-1-CARD corresponds to residues 108–116 in ASC. The region 108–112 is significantly flexible according to NMR relaxation data (see below), thus confirming the absence of H1a in ASC. The lack of H1a in the CARD of ASC might be related to its plasticity in protein-protein interactions that could facilitate participation in apoptotic and inflammatory events. In addition, large deviations in the orientation of helices 2 and 3 are also observed (Fig. 3C), which can result from the propagation of structural changes in the binding surface involving the connection between H1a and H1b. The electrostatic surface of full-length ASC CARD is significantly different from Apaf-1 CARD (Fig. 3D). ASC shows positively and negatively charged areas evenly spread throughout the surface, whereas Apaf-1-CARD shows two extensive oppositely charged patches (Fig. 3D). Within a similar fold, CARDs show structural differences pertaining to helix length, orientation (1), and electrostatic surface (examples are illustrated in supplemental Fig. S4), which might serve as a fine-tuned mechanism to tightly control the binding specificity observed in protein-protein interactions mediated by these domains.

Interdomain Dynamics in ASC

NMR relaxation of backbone amide (15N) measured as heteronuclear Overhauser values ({1H}-15N NOE) as well as longitudinal (T1) and transverse (T2) relaxation times are affected by N-H bond dynamics and the molecule's rotational diffusion (58, 59). Residues adopting regular secondary structure show heteronuclear NOE values close to the theoretical maximum (∼0.83 at a spectrometer frequency of 600 MHz), whereas values lower than ∼0.65 are symptomatic of internal dynamics (43, 60). The average heteronuclear NOE values for the PYD and CARD regions of ASC are high and similar (0.78 ± 0.07 and 0.79 ± 0.08, respectively) as expected for two rigid structures (Fig. 5A). In contrast, heteronuclear NOE values decrease from the PYD C terminus and the CARD N terminus toward the linker center (Fig. 5A). These results indicate that the linker undergoes local motions on a fast time scale compared with molecular tumbling. These motions become increasingly restricted toward the connections to the DDs. Thus, the heteronuclear NOE data indicate that ASC comprises two well ordered rigid domains connected by a flexible linker.

FIGURE 5.

FIGURE 5.

Backbone 15N amide NMR relaxation data of full-length ASC. A, amide {1H}-15N NOE values versus residue number are shown. Arrows indicate PYD and CARD length. B, 15N relaxation time ratios (T1/T2) versus residue number are shown. Straight lines indicate average T1/T2 values of each domain.

The next step is to analyze the dynamic behavior of each domain relative to the other. Two extreme models for ASC interdomain dynamics can be envisioned; in the first, both domains tumble as a single rigid body, and in the second model, each domain is dynamically independent. Backbone amide 15N T1/T2 ratios are particularly useful in this type of analysis, as they are similar among the domains when they tumble as a whole and different otherwise (43). The 15N T1/T2 ratios of the PYD and CARD of ASC are noticeably different, indicating that they reorient at different rates (Fig. 5B). In addition, NMR relaxation-derived τc values of ASC individual domains are significantly larger than the predicted values (Table 1). Theoretical and NMR τc values of globular proteins are generally in very good agreement. As an example, Table 1 shows the theoretical and experimental τc values of the PYD-only protein ASC2 (56) of similar size and structure to ASC individual domains. The NMR τc values of both PYD and CARD in ASC are also larger than the experimental τc of ASC2, indicating that the former do not tumble independently. These results suggest that the PYD and CARD in ASC are in between the two extreme models, showing some interdomain flexibility and simultaneously sensing each domain the drag of the other.

This behavior is structurally illustrated by superimposing each individual domain of the NMR conformational ensemble (Fig. 6). The residual structural preferences of the linker result in a defined spatial interdomain organization that determines the orientation for binding of one domain relative to the other. Within this topological arrangement the flexibility of the linker increases the accessible space sampled by each domain, improving therefore, the chances to find interacting partners relative to proteins with two structurally fixed domains.

FIGURE 6.

FIGURE 6.

Superposition of the 10 lowest energy conformers of full-length human ASC. A, individual superposition of the PYD is shown. Helices are numbered and colored in red (front helices) and orange (back helices). The linker and CARD are colored in yellow and green, respectively. B, individual superposition of the CARD is shown. Helices are numbered and colored in dark green (front helices) and light green (back helices). The linker and PYD are colored in yellow and orange, respectively.

Interdomain motions caused by linker flexibility have been related to protein function. A classical example is the NMR study on the dynamic behavior of the two-domain protein calmodulin (43). This study shows that the long interdomain linker is highly mobile, supporting its role in calmodulin versatility to bind to multiple partners. Moreover, the linker flexibility is proposed to allow both protein halves to simultaneously interact with the target and to adopt the different domain orientations required in the formation of each complex. The binding requirements of ASC and calmodulin are analogous in that both proteins need to interact with different partners. Therefore, the flexibility of the linker could play a similar role in the interdomain dynamics of both proteins. Nevertheless, an important difference in the behavior of ASC could be that each domain binds at least one different target to form a particular complex. Like ASC, calmodulin domains show NMR relaxation-derived τc values that are significantly larger than the prediction (Table 1) albeit smaller than the correlation time expected for a globular protein of similar size (43). Interdomain motions in calmodulin have been further studied, resulting in the determination of the motion time scale (61). Examples of proteins with domain dynamics fitting the first extreme scenario explained above have also been reported (62). In this case the domains orient together because short or rigid linkers connect them or because they participate in interdomain contacts. In the death domain superfamily, FADD serves as an example of two domains orienting as a whole (23).

A Model for ASC Oligomerization

ASC forms homo- and hetero-oligomeric assemblies that are tightly bound to its function. NMR data and AFM images reported here indicate that ASC is also capable of self-associating in vitro (Figs. 1 and 2). Based on this information and the propensity of death domains to form homotypic interactions within subfamilies, it is possible to build a model to illustrate how ASC could oligomerize. The model (Fig. 7A) uses the structure of full-length ASC as the monomer template together with the binding interface of Apaf-1-CARD-caspase-9-CARD complex structure (27), which is currently the single three-dimensional CARD/CARD complex structure known. The structure of a PYD/PYD complex has not been determined up to date.

FIGURE 7.

FIGURE 7.

Molecular model of the ASC dimer and representation of the interacting region of the PYD in the electrostatic surface and as a ribbon diagram. A, left, shown is a model of the ASC dimer. The 10 lowest energy conformers of ASC CARD are superimposed and colored in red and dark blue. PYDs are colored in yellow and light blue. Right, CARDs in the dimer model showing the relative orientation of the central axes (green cylinders) that form an angle of 53.6°. The central axes and angle were calculated with the program MOLMOL (42) using the Cα atoms of the fragment 155–184 comprising helices 4 and 5, which is in the center of the CARD structure. B, left, shown is the electrostatic surface of human ASC indicating the PYD. Negatively and positively charged surfaces are colored in red and blue, respectively. Right, a ribbon diagram of ASC PYD inside its volume is shown. The negatively and positively charged helices suggested to interact are highlighted in red and blue. The remaining helices are orange. The 10 lowest energy conformers of the CARD are shown (green) to indicate their accessible space. The linker is colored in yellow. The orientation of the PYD in the left and right figures is the same to show the electrostatic surface of the interacting helices.

The CARD/CARD interaction is asymmetric, involving helices 1 and 4 of one CARD and helices 2 and 3 of the other (Fig. 7A). The asymmetry leaves two free binding sites in the dimer: helices 1 and 4 of one monomer and helices 2 and 3 of the other. The free binding sites allow additional CARD/CARD interactions, naturally leading to oligomerization. PYD/PYD interactions are suggested to also involve helices 1 and 4 of one PYD and helices 2 and 3 of the other (25). The PYD/PYD interface would be asymmetric and, therefore, would leave free binding sites upon dimer formation. Thus, the PYDs could as well participate in the self-association of ASC through homophilic interactions. The formation of the CARD/CARD and PYD/PYD interaction in the dimer model pre-establishes the relative binding orientation of the each domain to other partners (Fig. 7A). Moreover, in this model the pyrin domains are confined to a restrained space on top of the CARDs and do not obstruct the CARD/CARD interface (Fig. 7A). Interestingly, in the ASC structure the helices suggested to participate in the PYD/PYD interface are positioned as far as possible from the CARD and are, therefore, accessible for interactions with other partners (Fig. 7B). Thus, the CARD does not interfere with the PYD interface suggested to be involved in PYD/PYD interactions.

The CARDs central axes in the dimer model are positioned at an angle (Fig. 7A) that could result in the formation of a ring upon further association through the free interacting surfaces. The value of this angle (53.6°) is consistent with a ring composed of ∼6–7 monomers. Strikingly, electron microscopy data of the supramolecular apoptosome formed by Apaf-1 oligomerization show a 7-member CARD ring (63). In addition, the protein NALP1, which bears an N-terminal PYD and a C-terminal CARD flanking other domains, also forms a 7-fold symmetric ring as observed by electron microscopy (18). Both are rings of ∼12–13-nm outer diameter. Interestingly, the disk-like ASC oligomers (Fig. 2) of ∼12-nm diameter suggest that ASC could oligomerize into rings analogous to those formed by Apaf-1 and NALP1. However, ASC has been shown by confocal microscopy to also form rather large specks of ∼2 μm in diameter (8) and filaments (2). These results together with the AFM data reported here suggest that the oligomerization of ASC could be a complex process. It is likely that the disk-like oligomers observed by AFM further aggregate into larger assemblies.

DISCUSSION

This study shows how the molecular architecture of ASC facilitates self-association and multiple binding to several proteins, which in turn could result in the assembly of supramolecular platforms. This role directly emerges from ASC interdomain orientation and dynamics. ASC interdomain topological organization facilitates binding by avoiding steric interference between the two domains and favors a specific protein binding orientation. In addition to spatial confinement, ASC shows interdomain flexibility, which is proposed to increase the search space of each domain independently, therefore, enhancing the probability to find interacting partners. The interdomain structural and dynamic properties of ASC are significantly different from FADD, which is the only other protein structure currently known with two death domains belonging to different subfamilies. The length of the linker (23 amino acids in ASC and 6 amino acids in FADD) could be partially responsible for the observed differences between the two proteins and, therefore, might emerge as an important factor in the operating mode of death domain proteins.

The oligomerization of ASC is another distinctive characteristic related to its capability to form supramolecular assemblies. The absence of intramolecular PYD/CARD interactions in the structure of ASC agrees with all structural and biochemical data of death domains reporting their tendency to form homophilic interactions within each subfamily and suggests that ASC oligomerizes through homotypic interactions mediated by its CARD and PYD. The overall dimension and shape of these oligomers are reported here. Interestingly, ASC oligomers are disk-like particles of similar size to the Apaf-1 CARD and NALP1 rings. Taken together, the structural and dynamic features of ASC shed light into the function of this protein as an adapter molecule and its capability to form supramolecular complexes in apoptosis and inflammation. Further research in this area will help to establish whether other members of the death domain superfamily, with multiple protein-protein binding domains connected by relatively long linkers, share some of these structural features and behave similarly.

Supplementary Material

Supplemental Data

Acknowledgments

The gift of ASC cDNA from Professor Gabriel Núñez is greatly appreciated. Dr. Nico Tjandra is acknowledged for software used in magnetic relaxation analysis. The suggestions of Professor Víctor Muñoz for manuscript preparation are also acknowledged. The assistance from Jörg Schönfelder in AFM experiments is greatly appreciated.

*

This work was supported by the European Commission Marie Curie International Reintegration Grant IRG-046412 (to E. d. A.), by the Spanish Ministerio de Ciencia e Innovación through the Programa Ramón y Cajal (to E. d. A.), by Plan Nacional I+D+I Grant BFU2008-03278 (to E. d. A.), and by Comunidad de Madrid and Agencia CSIC through the IV PRICIT CCG08-CSIC/SAL-3777 (to E. d. A.).

Inline graphic

The on-line version of this article (available at http://www.jbc.org) contains supplemental Tables S1 and S2 and Figs. S1–S4.

The atomic coordinates (code 2KN6) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

2
The abbreviations used are:
DD
death domain
DED
death effector domain
CARD
caspase recruitment domain
PYD
pyrin domain
ASC
apoptosis-associated speck-like protein containing a CARD
NOE
nuclear Overhauser effect
AFM
atomic force microscopy
HSQC
heteronuclear single quantum correlation
3D
three-dimensional
NOESY
NOE spectroscopy
TOCSY
total correlation spectroscopy.

REFERENCES

  • 1.Park H. H., Lo Y. C., Lin S. C., Wang L., Yang J. K., Wu H. (2007) Annu. Rev. Immunol. 25, 561–586 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Masumoto J., Taniguchi S., Ayukawa K., Sarvotham H., Kishino T., Niikawa N., Hidaka E., Katsuyama T., Higuchi T., Sagara J. (1999) J. Biol. Chem. 274, 33835–33838 [DOI] [PubMed] [Google Scholar]
  • 3.Conway K. E., McConnell B. B., Bowring C. E., Donald C. D., Warren S. T., Vertino P. M. (2000) Cancer Res. 60, 6236–6242 [PubMed] [Google Scholar]
  • 4.Ohtsuka T., Ryu H., Minamishima Y. A., Macip S., Sagara J., Nakayama K. I., Aaronson S. A., Lee S. W. (2004) Nat. Cell Biol. 6, 121–128 [DOI] [PubMed] [Google Scholar]
  • 5.Hasegawa M., Kawase K., Inohara N., Imamura R., Yeh W. C., Kinoshita T., Suda T. (2007) Oncogene 26, 1748–1756 [DOI] [PubMed] [Google Scholar]
  • 6.McConnell B. B., Vertino P. M. (2000) Cancer Res. 60, 6243–6247 [PubMed] [Google Scholar]
  • 7.Masumoto J., Dowds T. A., Schaner P., Chen F. F., Ogura Y., Li M., Zhu L., Katsuyama T., Sagara J., Taniguchi S., Gumucio D. L., Núñez G., Inohara N. (2003) Biochem. Biophys. Res. Commun. 303, 69–73 [DOI] [PubMed] [Google Scholar]
  • 8.Fernandes-Alnemri T., Wu J., Yu J. W., Datta P., Miller B., Jankowski W., Rosenberg S., Zhang J., Alnemri E. S. (2007) Cell Death Differ. 14, 1590–1604 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.McConnell B. B., Vertino P. M. (2004) Apoptosis 9, 5–18 [DOI] [PubMed] [Google Scholar]
  • 10.Mariathasan S. (2007) Microbes Infect. 9, 664–671 [DOI] [PubMed] [Google Scholar]
  • 11.Pétrilli V., Martinon F. (2007) Joint Bone Spine 74, 571–576 [DOI] [PubMed] [Google Scholar]
  • 12.Taniguchi S., Sagara J. (2007) Semin. Immunopathol. 29, 231–238 [DOI] [PubMed] [Google Scholar]
  • 13.Martinon F., Burns K., Tschopp J. (2002) Mol. Cell 10, 417–426 [DOI] [PubMed] [Google Scholar]
  • 14.Tschopp J., Martinon F., Burns K. (2003) Nat. Rev. Mol. Cell Biol. 4, 95–104 [DOI] [PubMed] [Google Scholar]
  • 15.Srinivasula S. M., Poyet J. L., Razmara M., Datta P., Zhang Z., Alnemri E. S. (2002) J. Biol. Chem. 277, 21119–21122 [DOI] [PubMed] [Google Scholar]
  • 16.Stehlik C., Lee S. H., Dorfleutner A., Stassinopoulos A., Sagara J., Reed J. C. (2003) J. Immunol. 171, 6154–6163 [DOI] [PubMed] [Google Scholar]
  • 17.Kanneganti T. D., Ozören N., Body-Malapel M., Amer A., Park J. H., Franchi L., Whitfield J., Barchet W., Colonna M., Vandenabeele P., Bertin J., Coyle A., Grant E. P., Akira S., Núñez G. (2006) Nature 440, 233–236 [DOI] [PubMed] [Google Scholar]
  • 18.Faustin B., Lartigue L., Bruey J. M., Luciano F., Sergienko E., Bailly-Maitre B., Volkmann N., Hanein D., Rouiller I., Reed J. C. (2007) Mol. Cell 25, 713–724 [DOI] [PubMed] [Google Scholar]
  • 19.Eisenbarth S. C., Colegio O. R., O'Connor W., Sutterwala F. S., Flavell R. A. (2008) Nature 453, 1122–1126 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ogura Y., Sutterwala F. S., Flavell R. A. (2006) Cell 126, 659–662 [DOI] [PubMed] [Google Scholar]
  • 21.Mariathasan S., Newton K., Monack D. M., Vucic D., French D. M., Lee W. P., Roose-Girma M., Erickson S., Dixit V. M. (2004) Nature 430, 213–218 [DOI] [PubMed] [Google Scholar]
  • 22.Fernandes-Alnemri T., Alnemri E. S. (2008) Methods Enzymol. 442, 251–270 [DOI] [PubMed] [Google Scholar]
  • 23.Carrington P. E., Sandu C., Wei Y., Hill J. M., Morisawa G., Huang T., Gavathiotis E., Wei Y., Werner M. H. (2006) Mol. Cell 22, 599–610 [DOI] [PubMed] [Google Scholar]
  • 24.Yang J. K., Wang L., Zheng L., Wan F., Ahmed M., Lenardo M. J., Wu H. (2005) Mol. Cell 20, 939–949 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Liepinsh E., Barbals R., Dahl E., Sharipo A., Staub E., Otting G. (2003) J. Mol. Biol. 332, 1155–1163 [DOI] [PubMed] [Google Scholar]
  • 26.Zhou P., Chou J., Olea R. S, Yuan J., Wagner G. (1999) Proc. Natl. Acad. Sci. U.S.A. 96, 11265–11270 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Qin H., Srinivasula S. M., Wu G., Fernandes-Alnemri T., Alnemri E. S., Shi Y. (1999) Nature 399, 549–557 [DOI] [PubMed] [Google Scholar]
  • 28.Shoemaker B. A., Portman J. J., Wolynes P. G. (2000) Proc. Natl. Acad. Sci. U.S.A. 97, 8868–8873 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.de Alba E. (2007) Biomol. NMR Assign. 1, 135–137 [DOI] [PubMed] [Google Scholar]
  • 30.Bax A., Grzesiek S. (1993) Acc. Chem. Res. 26, 131–138 [Google Scholar]
  • 31.Cavanagh J., Fairbrother W. J., Palmer A. G., Rance M., Skelton N. J. (2006) in Protein NMR Spectroscopy: Principles and Practice, Academic Press, Inc, San Diego, CA [Google Scholar]
  • 32.Delaglio F., Grzesiek S., Vuister G. W., Zhu G., Pfeifer J., Bax A. ( 1995) J. Biomol. NMR 6, 277– 293 [DOI] [PubMed] [Google Scholar]
  • 33.Garret D. S., Powers R., Gronenborn A., Clore G. M. (1991) J. Magn. Reson. 95, 214–220 [DOI] [PubMed] [Google Scholar]
  • 34.Tjandra N., Bax A. (1997) Science 278, 1111–1114 [DOI] [PubMed] [Google Scholar]
  • 35.Hansen M. R., Mueller L., Pardi A. (1998) Nat. Struct. Biol. 5, 1065–1074 [DOI] [PubMed] [Google Scholar]
  • 36.Clore G. M., Starich M. R., Gronenborn A. M. (1998) J. Am. Chem. Soc. 120, 10571–10572 [Google Scholar]
  • 37.Nilges M. (1993) Proteins 17, 297–309 [DOI] [PubMed] [Google Scholar]
  • 38.Cornilescu G., Delaglio F., Bax A. (1999) J. Biomol. NMR 13, 289–302 [DOI] [PubMed] [Google Scholar]
  • 39.Schwieters C. D., Kuszewski J. J., Tjandra N., Clore G. M. (2003) J. Magn. Reson. 160, 65–73 [DOI] [PubMed] [Google Scholar]
  • 40.Laskowski R. A., Rullmannn J. A., MacArthur M. W., Kaptein R., Thornton J. M. (1996) J. Biomol. NMR 8, 477–486 [DOI] [PubMed] [Google Scholar]
  • 41.Davis I. W., Leaver-Fay A., Chen V. B., Block J. N., Kapral G. J., Wang X., Murray L. W., Arendall W. B., 3rd, Snoeyink J., Richardson J. S., Richardson D. C. (2007) Nucleic Acids Res. 35, W375–W383 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Koradi R., Billeter M., Wüthrich K. (1996) J. Mol. Graph. 14, 51–55 [DOI] [PubMed] [Google Scholar]
  • 43.Barbato G., Ikura M., Kay L. E., Pastor R. W., Bax A. (1992) Biochemistry 31, 5269–5278 [DOI] [PubMed] [Google Scholar]
  • 44.Grzesiek S., Bax A. (1993) J. Am. Chem. Soc. 115, 12593–12594 [Google Scholar]
  • 45.Tjandra N., Wingfield P., Stahl S., Bax A. (1996) J. Biomol. NMR 8, 273–284 [DOI] [PubMed] [Google Scholar]
  • 46.Tjandra N., Feller S. E., Pastor R. W., Bax A. (1995) J. Am. Chem. Soc. 117, 12562–12566 [Google Scholar]
  • 47.Schanda P., Brutscher B. (2005) J. Am. Chem. Soc. 127, 8014–8015 [DOI] [PubMed] [Google Scholar]
  • 48.Brüschweiler R., Liao X., Wright P. E. (1995) Science 268, 886–889 [DOI] [PubMed] [Google Scholar]
  • 49.Daragan V. A., Mayo K. H. (1997) Prog. NMR Spectrosc. 31, 63–105 [Google Scholar]
  • 50.Wagner G. (1993) J. Biomol. NMR 3, 375–385 [DOI] [PubMed] [Google Scholar]
  • 51.Moriya M., Taniguchi S., Wu P., Liepinsh E., Otting G., Sagara J. (2005) Biochemistry 44, 575–583 [DOI] [PubMed] [Google Scholar]
  • 52.Spera S., Bax A. (1991) J. Am. Chem. Soc. 113, 5490–5492 [Google Scholar]
  • 53.Dyson H. J., Wright P. E. (2005) Nat. Rev. Mol. Cell Biol. 6, 197–208 [DOI] [PubMed] [Google Scholar]
  • 54.George R. A., Heringa J. (2002) Protein Eng. 15, 871–879 [DOI] [PubMed] [Google Scholar]
  • 55.Hiller S., Kohl A., Fiorito F., Herrmann T., Wider G., Tschopp J., Grütter M. G., Wüthrich K. (2003) Structure 11, 1199–1205 [DOI] [PubMed] [Google Scholar]
  • 56.Natarajan A., Ghose R., Hill J. M. (2006) J. Biol. Chem. 281, 31863–31875 [DOI] [PubMed] [Google Scholar]
  • 57.Stehlik C., Krajewska M., Welsh K., Krajewski S., Godzik A., Reed J. C. (2003) Biochem. J. 373, 101–113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Palmer A. G., Williams J., McDermott A. (1996) J. Phys. Chem. 100, 13293–13310 [Google Scholar]
  • 59.Ishima R., Torchia D. A. (2000) Nat. Struct. Biol. 7, 740–743 [DOI] [PubMed] [Google Scholar]
  • 60.Kay L. E., Torchia D. A., Bax A. (1989) Biochemistry 28, 8972–8979 [DOI] [PubMed] [Google Scholar]
  • 61.Baber J. L., Szabo A., Tjandra N. (2001) J. Am. Chem. Soc. 123, 3953–3959 [DOI] [PubMed] [Google Scholar]
  • 62.Fushman D., Varadan R., Assfalg M., Walker O. (2004) Prog. NMR Spectrosc. 44, 189–214 [Google Scholar]
  • 63.Yu X., Acehan D., Ménétret J. F., Booth C. R., Ludtke S. J., Riedl S. J., Shi Y., Wang X., Akey C. W. (2005) Structure 13, 1725–1735 [DOI] [PubMed] [Google Scholar]
  • 64.Wishart D. S., Bigam C. G., Holm A., Hodges R. S., Sykes B. D. (1995) J. Biomol. NMR 5, 67–81 [DOI] [PubMed] [Google Scholar]
  • 65.Day C. L., Dupont C., Lackmann M., Vaux D. L., Hinds M. G. (1999) Cell Death Differ. 6, 1125–1132 [DOI] [PubMed] [Google Scholar]
  • 66.Humke E. W., Shriver S. K., Starovasnik M. A., Fairbrother W. J., Dixit V. M. (2000) Cell 103, 99–111 [DOI] [PubMed] [Google Scholar]
  • 67.Chou J. J., Matsuo H., Duan H., Wagner G. (1998) Cell 94, 171–180 [DOI] [PubMed] [Google Scholar]
  • 68.Manon F., Favier A., Núñez G., Simorre J. P., Cusack S. (2007) J. Mol. Biol. 365, 160–174 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Data

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES